Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma

Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma

Immune checkpoint inhibitors (ICI) have revolutionized the therapeutic landscape of metastatic melanoma. However, ICI are often associated with immune-related adverse events (IRAE) such as colitis, hepatitis, pancreatitis, hypophysitis, pneumonitis, thyroiditis, exanthema, nephritis, myositis, encep...

Full description

Bibliographic Details
Main Authors: Marcus Wölffer, Florian Battke, Martin Schulze, Magdalena Feldhahn, Lukas Flatz, Peter Martus, Andrea Forschner
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
immune-related adverse events
genetic alterations
immunotherapies
melanoma
Online Access:https://www.mdpi.com/2072-6694/14/2/302

Internet

https://www.mdpi.com/2072-6694/14/2/302

Similar Items